Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q1 2025 Earnings Call Transcript May 12, 2025
Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.83, expectations were $-0.94.
Operator: Thank you for standing by. My name is Carly, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q1 2025 Xenon Pharmaceuticals Earnings Conference Call. [Operator Instructions] Thank you. I would now like to turn the call over to Chad Fugere,...
